© 2017 - 2018 BRMass




  • Stanford University, 2012 - 2015
  • Postdoctoral Fellow (Chemistry) Purdue University, 2008 - 2012
  • Ph.D. in Chemistry (Analytical Chemistry) State University of Campinas, 2004 – 2007
  • B.S. in Chemistry Awards 2015
  • K99/R00 NIH/NCI Pathway to Independence Award 2015
  • Named among “Forbes’ 30 under 30” list in Healthcare 2014
  • L’Oréal USA For Women in Science Fellowship 2014
  • American Chemical Society Nobel Laureate Signature Award for Graduate Education in Chemistry 2012
  • M.G. Mellon Award in Analytical Chemistry, Purdue University, IN, USA RESEARCH/LAB

DESCRIPTION: Research in the Eberlin group focuses on applying novel mass spectrometry imaging technology to health related research. Our main goal is to develop innovative ambient mass spectrometry techniques and methodologies in combination with statistical and molecular biology tools to investigate the molecular information from a variety of biological samples. In particular, we are interested in using ambient mass spectrometry in creative ways to address critical problems in cancer research. Using ambient mass spectrometry, we investigate the metabolic profiles of tissues and other clinical specimens. We correlate the metabolic information obtained with molecular and clinical data to better understand and diagnose disease.

In basic cancer research, we are interested in studying tumor tissue behavior and chemically characterizing metabolic signatures of human cancers. We also pursue improvements in MS instrumentation in order to translate the tools developed in the laboratory to the clinic for in situ, real-time disease diagnosis. Our interdisciplinary research is carried out in collaboration with biologists, oncologists, surgeons, pathologists and statisticians to develop powerful approaches that can be used in real life scenarios such as in clinical practice. For more information on our exciting research projects, please visit our group website (under construction)."